Kidney disease itching, known clinically as CKD-associated pruritus, responds to a combination of daily skin care, prescription medications, dialysis adjustments, and light therapy. No single fix works for everyone, and the itch tends to resist ordinary antihistamines because it is driven by internal chemical imbalances rather than a typical allergic reaction. The good news is that treatment options have expanded considerably in recent years, including the first drug specifically approved for this type of itch. Getting relief usually means layering several strategies together and working with your kidney care team to find the right mix.
Why Kidney Disease Makes You Itch
Understanding the cause helps explain why some remedies work and others fall flat. When your kidneys lose filtering capacity, waste products and inflammatory molecules build up in the blood. This accumulation has been linked to itching for decades, but researchers now know the picture is more complicated than just “toxins in the blood.” Several overlapping mechanisms appear to be at work.
One major driver is inflammation. People on hemodialysis who report itching tend to have significantly higher blood levels of interleukin-31 (IL-31), a signaling molecule that activates itch-sensing nerve fibers in the skin. In one study, dialysis patients with itching had mean IL-31 levels roughly four times higher than dialysis patients without itching and more than ten times higher than healthy controls.1PubMed Central. The Serum Level of IL-31 in Patients with Chronic Kidney Disease-Associated Pruritus: What Can We Expect? Other inflammatory markers, including C-reactive protein and additional cytokines, are also elevated in people with this type of itch, amplifying the signals that travel from skin to brain.2PubMed Central. Chronic kidney disease-associated pruritus: a perspective on skin barrier damage
A second piece of the puzzle involves opioid signaling. Your body’s natural opioid system has two branches that, in healthy people, balance each other out: one (the mu-opioid pathway) tends to promote itch, and the other (the kappa-opioid pathway) tends to suppress it. In dialysis patients with itching, that balance shifts. Researchers have found lower levels of itch-suppressing opioids like beta-endorphin and dynorphin A, paired with higher levels of itch-promoting opioids, in people who itch compared to those who do not.3PubMed Central. Endogenous Opioid Imbalance as a Potential Factor Involved in the Pathogenesis of Chronic Kidney Disease-Associated Pruritus in Dialysis Patients This imbalance is directly targeted by some of the newer medications discussed below.
On top of all this, mineral abnormalities play a role. As kidney function declines, calcium, phosphorus, and parathyroid hormone levels can drift out of range. A higher rate of itching has been observed in patients with overactive parathyroid glands, though treating the parathyroid problem does not always resolve the itch, which underscores how many factors are involved.4Nefrología (English Edition). Etiopathogenesis of chronic kidney disease-associated pruritus: putting the pieces of the puzzle together
Start With Your Skin
The simplest first step is aggressive moisturizing, and it is also the most underused. Kidney disease dries out the skin (a condition called xerosis), and dry, cracked skin itches on its own even before you layer on the internal causes. In a controlled trial, dialysis patients who applied a high-water-content emollient gel twice daily saw their itch scores drop dramatically within two weeks, from an average of about 3.5 out of 10 down to 0.6. When the emollient was stopped, itch scores crept back up and skin dryness returned in about 40 percent of patients within two weeks.5PubMed. Effect of skin care with an emollient containing a high water content on mild uremic pruritus The takeaway is straightforward: moisturize consistently, and do not stop when things feel better.
A few practical tips for skin care when you have CKD-related itching:
- Choose fragrance-free emollients: Look for creams or ointments rather than thin lotions, which evaporate quickly. Ceramide-containing products help restore the skin’s natural barrier.
- Apply right after bathing: Pat your skin mostly dry and apply cream within a few minutes while pores are still slightly open and the skin is damp.
- Keep showers short and lukewarm: Hot water strips oils from the skin and can trigger or worsen itch episodes.
- Avoid harsh soaps: Mild, soap-free cleansers with a neutral pH are much gentler on skin that is already compromised.
Emollient therapy alone will not eliminate moderate or severe itching, but it reduces the baseline itch level and makes other treatments work better. Think of it as the foundation you build everything else on top of.
Prescription Medications That Target the Itch
When skin care is not enough, prescription options exist that go after the neurological and opioid pathways fueling the itch. Two categories stand out in the evidence.
Gabapentinoids
Gabapentin and pregabalin, originally developed for nerve pain and seizures, are among the most studied treatments for CKD-related itching. A Cochrane systematic review, which represents the highest level of evidence synthesis, found that gabapentinoids produced the greatest reduction in itch scores of all treatments evaluated for uremic pruritus, with high-certainty evidence supporting their use.6PubMed. Interventions for itch in people with advanced chronic kidney disease
In clinical practice, gabapentin relieves itching in roughly two-thirds of patients. For those who experience side effects from gabapentin (drowsiness, dizziness, and unsteadiness are the most common, affecting more than a third of users), pregabalin is a reasonable alternative. In one series, pregabalin relieved itching in about 80 percent of patients who had to stop gabapentin due to side effects. Across both drugs, around 85 percent of patients found relief, with median itch severity dropping from 8 out of 10 to just 1.7PubMed. Uraemic pruritus: relief of itching by gabapentin and pregabalin A head-to-head comparison confirmed that both drugs reduce itching intensity to a similar degree.8PubMed Central. Comparison of Safety and Efficacy of Pregabalin versus Gabapentin for the treatment of Uremic Pruritus in Patients with Chronic Kidney Disease on Maintenance Haemodialysis
One important caveat: both drugs are cleared by the kidneys, so doses must be adjusted downward for people with reduced kidney function. Your nephrologist will typically start with a low dose given after dialysis sessions and titrate up carefully.
Difelikefalin
In 2021, the FDA approved difelikefalin (brand name Korsuva) as the first drug specifically for moderate-to-severe itching in adults undergoing hemodialysis.9PubMed Central. Kappa opioid agonists in the treatment of itch: just scratching the surface? It works by activating the kappa-opioid receptors that suppress itch, directly correcting the opioid imbalance described earlier. Because the drug does not cross into the brain, it avoids the sedation and mood effects associated with traditional opioids.
In the pivotal trial, about half of patients receiving difelikefalin had a meaningful reduction in itch (a drop of at least 3 points on a 0-to-10 scale), compared with roughly 28 percent of those on placebo. Patients also reported significant improvements in itch-related quality of life.10PubMed. A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus Real-world data over 12 months has been encouraging too. In one cohort of patients with itching that had not responded to other treatments, average itch scores dropped by about half (from 8 out of 10 to roughly 4) over a year of use, and sleep disturbance scores also improved significantly.11PubMed. Real-world effectiveness and tolerability of difelikefalin over 12 months for hemodialysis-associated pruritus
Difelikefalin is given intravenously at the end of each dialysis session, which makes it convenient if you are already on in-center hemodialysis. It is not yet available for people with CKD who are not on dialysis, though studies in that population are ongoing.
Getting More Out of Dialysis
If you are on hemodialysis, how well your sessions clear waste from your blood has a direct relationship with itching. A large study found that lower dialysis adequacy scores were an independent predictor of worse itching. The same study showed that patients dialyzed through high-flux membranes were less likely to have severe itching than those using older low-flux filters.12PubMed Central. Uremic Pruritus in Hemodialysis: Mechanisms, Burden, and Emerging Therapies High-flux membranes do a better job removing medium-sized molecules like beta-2-microglobulin, which has itself been linked to itch. Multiple studies have confirmed this benefit.13Jundishapur Journal of Chronic Disease Care. Non-Pharmacological Treatments of Pruritus in Hemodialysis Patients: A Review Study
If your itching is severe and you are using low-flux dialysis or your adequacy numbers are borderline, it is worth asking your care team whether switching membranes or adjusting session length or frequency could help. This is not a dramatic intervention; it is a technical change in how your dialysis is delivered that could take the edge off your symptoms.
Phototherapy With Narrowband UV Light
Narrowband ultraviolet B (NB-UVB) phototherapy is a well-established dermatology treatment that has been adapted for kidney-related itching. It works by calming immune activity in the skin and altering the nerve signaling that drives itch sensation. The treatment involves standing in a light booth two to three times per week, typically for a course of several weeks.
Results are consistently positive across studies. In one prospective trial, patients started noticing improvement by the sixth session, with nearly all patients achieving full relief by the end of their treatment course (an average of about 13 sessions).14PubMed Central. Effectiveness of Narrowband Ultraviolet Light in Chronic Kidney Disease-Associated Pruritus Another study found that average itch scores dropped from about 8.5 out of 10 at the start to roughly 4.8 by eight weeks, with higher UV doses producing greater improvement.15PubMed Central. Therapeutic Effectiveness of Narrowband-Ultraviolet B Phototherapy in Uremic Pruritus Patients with Chronic Kidney Disease Undergoing Hemodialysis – A Prospective Study
An interesting finding connects phototherapy to vitamin D. Researchers discovered that patients whose vitamin D levels rose the most during NB-UVB treatment responded faster and more completely. A rise in vitamin D above a certain threshold was independently associated with being a “rapid responder” to the therapy.16Kidney Research and Clinical Practice. Vitamin D and narrowband ultraviolet B phototherapy for chronic kidney disease-associated pruritus This does not mean taking vitamin D supplements alone will stop the itch, but it does suggest that correcting vitamin D deficiency (extremely common in CKD patients) may make other treatments work better.
Phototherapy requires access to a medical UV unit, usually in a dermatology office. It is safe for the kidneys, but it is not practical for everyone given the time commitment of multiple weekly visits.
Complementary Approaches
If you are looking beyond conventional treatments or want to add something alongside them, a few complementary therapies have reasonable evidence behind them. A systematic review of randomized controlled trials found that acupuncture, acupressure, and topical capsaicin each showed effectiveness in improving uremic pruritus.17PubMed. Complementary and alternative medicine therapies for uremic pruritus – A systematic review of randomized controlled trials
Capsaicin, the compound that makes chili peppers hot, is available as an over-the-counter cream (usually in 0.025% to 0.075% concentrations). Applied to itchy areas, it depletes the nerve chemical that transmits itch signals. It stings or burns when you first start using it, and that sensation fades with regular use over several days. It works best for localized itching rather than whole-body itch.
Acupuncture and acupressure at specific points (particularly one called LI11 on the forearm) have been tested in multiple small trials, and a meta-analysis concluded they appear effective for reducing itch scores.18PubMed Central. Efficacy of acupoint stimulation as a treatment for uremic pruritus: A systematic review and meta-analysis These are low-risk options, though the quality of the evidence is not as strong as what supports gabapentinoids or difelikefalin.
Why Treating the Itch Matters Beyond Comfort
Kidney disease itching is not just annoying. It has measurable effects on mental health, sleep, and overall outcomes. In a large cohort study, patients who reported being extremely bothered by itching were more than six times as likely to have depressive symptoms and roughly three times as likely to experience significant sleep disturbance and anxiety compared to patients without itching.19PubMed Central. Association of Chronic Kidney Disease–Associated Pruritus With the Sleep Disturbance, Depression, Pain, Anxiety, and Low Energy/Fatigue Symptom Cluster: A Retrospective Cohort Study Beyond quality of life, CKD-associated pruritus has been linked to higher rates of hospitalization and even increased mortality.20Clinical Kidney Journal. Epidemiology and burden of chronic kidney disease-associated pruritus
This is worth knowing because too many patients assume the itch is something they just have to live with, and too many clinicians under-prioritize it. If your care team does not routinely ask about itching, bring it up yourself. Itch is a treatable symptom, and letting it go unmanaged can spiral into poor sleep, worsened depression, and a declining sense of well-being that makes the entire burden of kidney disease heavier.
Tracking and Communicating Your Symptoms
One barrier to getting effective treatment is that itch is subjective and fluctuates. You might have a terrible night but feel fine during your clinic appointment, making it hard to convey the severity. Simple numerical rating scales where you rate your worst itch from 0 to 10 each day have been validated specifically for CKD-associated pruritus and are now widely used in clinical trials and clinical practice.21PubMed Central. Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus
Keeping a brief daily log of your worst itch score, what time the itch is worst, and what you were doing at the time gives your doctor something concrete to work with. It also helps you track whether a new treatment is actually making a difference or just seems like it on a good day. A drop of 3 or more points on that 0-to-10 scale is generally considered a meaningful improvement. If you have been on a treatment for several weeks and your scores have not budged by that much, it is reasonable to ask about adding or switching to something else.
When Antihistamines Do Not Work
Many people with kidney disease itch reach for diphenhydramine (Benadryl) or other over-the-counter antihistamines first, and most find them disappointing. This is not surprising given what drives the itch. Standard antihistamines block histamine, but CKD-associated pruritus is primarily driven by inflammatory cytokines and opioid imbalance rather than a histamine-mediated allergic reaction. The relief some people feel from antihistamines is likely due to the sedative effect (you fall asleep before you notice the itch) rather than any direct anti-itch action.
Sedating antihistamines also carry risks for people with kidney disease. Drowsiness can compound the fatigue that already accompanies CKD, and some antihistamines are cleared through the kidneys, meaning they can accumulate to levels that cause confusion, dry mouth, or urinary problems. If you have been relying on antihistamines and they are not working, that does not mean the itch is untreatable. It means you need treatments that target the actual mechanisms involved.
Putting a Strategy Together
Because multiple mechanisms contribute to CKD-related itching, the most effective approach typically layers interventions. A reasonable starting framework looks something like this:
- Foundation: Daily emollient use, gentle skin care habits, and optimized dialysis (if applicable).
- First-line medication: Gabapentin or pregabalin, adjusted for kidney function and given after dialysis sessions.
- Add-on or alternative: Difelikefalin for hemodialysis patients with moderate-to-severe itching that persists, or NB-UVB phototherapy if access is available.
- Complementary extras: Topical capsaicin for localized patches, acupressure for general itch, and vitamin D correction if levels are low.
Not every person will need all of these layers. Someone with mild itching may find that consistent moisturizing and correcting dry skin is enough. Someone with severe, sleep-disrupting itch may need gabapentin plus difelikefalin plus phototherapy before they feel normal. The key is treating this as a problem worth solving systematically rather than a nuisance to endure, and revisiting your strategy if the first attempt does not bring your itch scores down meaningfully within a few weeks.